Alivus Life Sciences Ltd.

BSE: 543322 | NSE: ALIVUS
Small Cap | Pharmaceuticals & Drugs
1050.35
-10.40 (-0.98%)
< Home < Back

Alivus Life Sciences informs about disclosure

Date: 21-03-2026
Pursuant to regulation 30(2) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (LODR Regulations) read with clause 20 of Para A of Part A of Schedule III of the LODR Regulations, Alivus Life Sciences has informed that the details of Intimation/Order received by the Company from Income Tax Department is enclosed as Annexure A.

The above information is a part of company’s filings submitted to BSE.